An estimated 2.8 million people worldwide are living with multiple sclerosis (MS), according to the National MS Society.

A second clinical trial testing fenebrutinib for MS has met its main goal, once again beating approved Aubagio in reducing ...

Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when started earlier.

Among adults with relapsing MS who received ublituximab, the annualized relapse rate continued to drop with up to 5 years of ...

PHOENIX — Two new datasets support the use of potent disease-modifying therapies (DMTs) during pregnancy in women with active multiple sclerosis (MS), reinforcing a growing shift toward treatment when ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study examined the ...

With March being MS Awareness Month, we sat down with Everclear’s Art Alexakis, who was diagnosed with the chronic autoimmune disease nearly 10 years ago.

Add Yahoo as a preferred source to see more of our stories on Google. Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Nearly one in five stable MS patients developed significant radiological inflammation after stopping first-line treatment. The median time to disease activity after discontinuing treatment was 12 ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...

NEW YORK (Reuters Health) - Treatment with immune-modulating drugs can benefit people with multiple sclerosis, or MS, but a study of physicians' prescribing patterns shows that most MS patients do get ...

Out-of-pocket costs for drugs used to treat neurologic diseases including dementia and Parkinson's disease (PD) have increased exponentially over the past 13 years with the most dramatic increase for ...